
...
By Ryan Smith
Senior Pop Culture & Entertainment Reporter
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Lottie Moss, the younger half-sister of supermodel Kate Moss, has revealed that she was rushed to the emergency room after overdosing on the popular diabetes drug Ozempic.
In recent years, celebrities and influencers alike have endorsed the drug as a fat-melting miracle. Stars have publicly discussed their experiences with Ozempic, subsequently sparking wider public interest in the drug. It has been reported that the demand has affected access for some who require it for medical purposes.
Ozempic is an injectable prescription drug that is used to manage blood sugar levels in patients with type 2 diabetes. It is based on a naturally occurring human hormone called glucagon-like peptide 1 (GLP-1), which plays an important role in regulating appetite and blood sugar levels.
Read More on Entertainment
The active ingredient in Ozempic is a molecule called semaglutide, which acts as a GLP-1 agonist. In other words, it mimics the structure of GLP-1 and activates its receptors. Studies have shown that people with obesity are often less sensitive to the hormones that make them feel full. But by slowing gastric emptying, drugs like Ozempic can restore feelings of fullness in these patients.

...
During the latest episode of her Dream On podcast, Lottie Moss revealed that she took Ozempic for two weeks "a few months ago" as she was not "feeling happy" about her weight. But, she recalled, she ended up having a seizure after taking a dose intended for a significantly heavier person.
"I had a friend, and she could get it for me," the British-born OnlyFans model said. "It was kind of below board... It was from a doctor, but it wasn't like you go into a doctor's office and he prescribes it for you, he takes your blood pressure and takes tests, which is what you need when you go on something like Ozempic."
Conceding that Ozempic is "not really meant for weight loss of people that aren't of a very large size," Lottie Moss added: "When I was taking it, the amount that I was taking was actually meant for people who are 100 kilos (220 pounds) and over and I'm in the 50s range. So it's these small things that I wish I'd known before taking it."
To avoid nausea, Lottie Moss said that she injected the drug into her leg, rather than her stomach, but said it was still "the worst decision I ever made."
Ozempic, manufactured by Danish multinational pharmaceutical company Novo Nordisk, is one of the brand names for semaglutide, which is also known as Wegovy. Unlike Ozempic, Wegovy—which is used off-label for weight loss—is specifically designed to treat obesity. Another popular drug is the tirzepatide Mounjaro, which works to reduce the appetite and better break down sugar and fat.
Safety and Well-being
In response to Lottie Moss' claims, a spokesperson for Novo Nordisk told Newsweek in a statement: "We understand and empathize with the health challenges this patient has faced. While we cannot comment on this particular incident, we care deeply about the safety and well-being of patients who take our medicines and strongly recommend that all patients maintain close contact with their health care professional for proper diagnosis, appropriate treatment, ongoing guidance and careful monitoring.
"It is important to note that Ozempic® (semaglutide injection) is for patients with type 2 diabetes and is a prescription-only medicine, meaning that it must be prescribed by a health care professional and should be taken as prescribed under their strict supervision. Patients must make any decisions about treatment together with their health care professional so that their doctor can assess whether it is appropriate to prescribe the medicine or not, based on their assessment of the patient's individual medical profile. Accessing prescription-only medicines without a valid prescription poses a direct danger to health.
"Above all, patient safety is our top priority at Novo Nordisk. We work closely with the U.S. Food and Drug Administration and all regulatory agencies around the world to continuously monitor the safety profile of our medicines."
Speaking on her podcast, Lottie Moss said of using Ozempic for weight loss: "This is a warning to everyone: Please, if you're thinking of taking it, do not take it, it's so not worth it."
"I would rather die any day than take that again. It made me feel so nauseous," she continued, adding that she had "never felt so sick in my life."
"I was throwing up, it was horrible," she recalled. "I took a lower dosage the first time I took it and then I went up higher. I ended up being in bed for like two days I think at one point, and felt so sick. My weight had dropped.
"I think I started at about 60 kilos (132 pounds), and I went down to 57 (125 pounds) with the first dose, then I went down to like 54 (119 pounds). It was crazy, I think my lowest was 53 (116 pounds). In terms of a few weeks, that's not a healthy weight loss, and that's not a healthy drop.
"When I was in bed for those two days and it was sort of the end of it and I was just wanting to come off it—because it's not like you can stop taking it, it's not like a pill or something that you don't take when you wake up in the morning, it's in your system and it's there.
"I felt so sick one day I said to my friend, 'I can't keep any water down, I can't keep any food down, no liquids, nothing. I need to go to hospital, I feel really sick.'"
Emergency Room Seizure
The model said that her eyes were "almost concaving in" by the time she decided to make a 3 a.m. visit to the emergency room. When she told the nurse the dose of Ozempic she had been taking, Lottie Moss recalled being told: "Oh my God, that's so not what you're meant to be taking."
During her time in the ER, she recalled feeling like she was "going to pass out" during a trip to the restroom.
"As soon as I got into the room where I was seen by another nurse... I literally had a seizure from how dehydrated I was, which honestly was one of the scariest things that's ever happened to me in my life," Lottie Moss said.
She said that her friend had to "hold my feet down. It was just so scary, the whole situation. I didn't know what was going on. My face was clenching up, my whole body was tense, my hands, it was so weird.... It was honestly horrible."
While Ozempic remains popular among those who are not obese and just wish to lose a little weight, Lottie Moss hopes that people learn from her ordeal.
"I hope by me talking about this and kind of saying my experience with it, it can be a lesson to some people that it's so not worth it," she said. "It's for diabetes, it's not for weight loss, really.
"I get that in the press right now and in the media, everyone and all these celebrities are on it right now and it's so hard to look at that and see these dramatic weight losses, especially for people with eating disorders and problems with eating. It's so hard to see that when maybe you're not someone who drops weight quickly or you're struggling with recovery and things like that. It's just so not what we need right now."
She also urged people to be happy with their weight, no matter their size. "Be happy you have a body that functions and works instead of putting it through something like that," she said. "It can be so detrimental in the future for your body."
Update 09/12/24, 12:59 a.m. ET: This article was updated to include a statement from Novo Nordisk.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines